Source: @norml @WeedConnection
Posted By: norml@weedconnection.com
media :: news - Tue, 21 Oct 2014 04:20:21 PST
Israeli Researchers To Study Anti-Tumor Effects of CBD In Cancer Patients
Jerusalem, Israel: Israeli investigators intend to evaluate the potential anti-tumoral effects of the canabinoid cannabidiol (CBD) in select cancer patients.
Researchers at the Hassadah Medical Center in Jerusalem will conduct a Phase II clinical trial to assess the impact of CBD as single treatment in cancer patients who have failed to respond to conventional therapies. Participants in the trial will receive CBD therapy for a period of eight weeks.
Ample data exists documenting the potent anti-cancer activity of various cannabinoids - including THC, CBD, and CBG - both in culture and in animal models. However, virtually no clinical trials exist reproducing these results in human subjects.
In August, pharmaceutical provider Insys Therapeutics announced that it had received orphan drug status for its proprietary formulation of CBD for the treatment of glioblastoma, a hard-to-treat aggressive form of brain cancer.
Organic CBD is classified under federal law as a schedule I controlled substance.
New Mexico: Appeals Court Says Medicinal Marijuana Costs Covered By Workers' Comp
Santa Fe, NM: Employers and insurance companies are legally obligated to cover the expense of medical cannabis for employees injured on the job, the New Mexico Court of Appeals has affirmed.
Writing for the court in Vialpando v. Ben's Automotive Services, Judge James Wechsler opined that the use of marijuana for pain management for injuries suffered while on the job constituted "reasonable and necessary care." The Judge determined that services specific to the use of medicinal cannabis are eligible for compensation even though the substance remains classified as a schedule I drug under federal law and may not be legally obtained at a licensed pharmacy.
The New Mexico Court of Appeals ruling is one of the first favorable court decisions involving cannabis and workers' rights. To date, the Supreme Courts of three states - California, Oregon, and Washington - have determined that state laws authorizing the physicians-supervised use of medical cannabis do not exempt patients from being fired for their off-the-job cannabis use. The Supreme Court for the state of Colorado is expected to rule on a similar matter imminently.
Canada: Nation's Largest Mental Health Group Calls For Legalizing Cannabis
Toronto, Canada: The production and sale of cannabis ought to be legally regulated in order to better mitigate social harms related to the plant's use, according to a policy statement published by the Canadian Centre for Addiction and Mental Health. The CAMH is Canada's largest mental health and addiction teaching hospital, as well as one of the world's leading research centers in the area of addiction and mental health.
"All available evidence indicates that criminalization of cannabis use is ineffective, costly, and constitutes poor public policy," the group acknowledged. "Legalization, combined with strict health-focused regulation, provides an opportunity to reduce the harms associated with cannabis use."
The CAMH's suggested regulations include a government monopoly on cannabis sales, the imposition of age-restrictions for those wishing to purchase cannabis, and a cap on the number of outlets allowed to sell the product.
"We want this framework to add to an informed discussion about the future of cannabis policy and to serve as a guide to the factors that need to be considered in order to come to a solution that is the most beneficial for public health," said Dr. Jürgen Rehm, Director of the Social and Epidemiological Research Department at CAMH. "We believe that the best solution is a system of legalization combined with strict regulation of cannabis."
Report: Purity Of So-Called Hemp-Based CBD Oils Questioned
San Rafael, CA: Cannabidiol (CBD)-infused oils marketed online as legal hemp products possess questionable potency and may contain various impurities, according to a report published this week by the non-profit advocacy group Project CBD.
According to the report, analytical testing of various products revealed significant quantities of industrial solvents, which could pose health risks to consumers. Potency testing also identified products with considerably lower levels of CBD and higher levels of THC than advertised.
The report also calls into question the notion that high-CBD extracts may be derived from industrial hemp plants. It states: "Cannabidiol can only be extracted from the flower, leaves, and, to a very minor extent, the stalk of the hemp plant. ... [T]hose who say they're extracting CBD only from the stalk of industrial hemp are almost certainly being disingenuous. Either they are bluffing to make it appear as though they are operating legally - or they are extracting the oil in a way that makes a dangerous product more likely."
Finally, the report discredits claims that such products are legal under federal law. "CBD-infused 'hemp oil' is not federally legal in all 50 states," Project CBD Director Martin Lee stated in a press release. "In some lab tests, ... products were found to have more than the legal limit of THC (0.03 percent, the percentage allowable under federal law in hemp food products). Moreover, cannabidiol in any form is still a Schedule One substance, according to the DEA and FDA."
Full text of the report is available online from Project CBD.org @ https://www.projectcbd.org/wp-content/uploads/2014/10/ProjectCBD_Special-Report_Medical-Marijuana.pdf
(c) Copyright 2006-2420 - WeedConnection LLC - ALL RIGHTS RESERVED
#Support Your #OG @WeedConnection! (Click Here)
